Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers F Khater et al, JAMA Network Open, April 25, 2019

Main|Search|PHGKB






Last Posted: Apr 28, 2019

---

• Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers
  F Khater et al, JAMA Network Open, April 25, 2019
• Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
  Waszak Sebastian M et al. The Lancet. Oncology 2018 19(6) 785-798
• The genomic landscape of pediatric cancers: Implications for diagnosis and treatment.
  Sweet-Cordero E Alejandro, et al. Science (New York, N.Y.) 2019 0 0. (6432) 1170-1175
• Updates on progress in cancer screening for children with hereditary cancer predisposition syndromes.
  Rednam Surya P et al. Current opinion in pediatrics 2018 Dec
• Cancer screening in the pediatric cancer patient: a focus on genitourinary malignancies, and why does a urologist need to know about this?
  Husmann D A et al. Journal of pediatric urology 2018 Oct
• Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
  Goschzik Tobias et al. The Lancet. Oncology 2018 Nov
• Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE).
  Wang Zhaoming et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Oct
• Genetic Profiling May Inform Breast Cancer Risk in Young Childhood Cancer Survivors
  AACR News, October 25, 2018
• Family-based germline sequencing in children with cancer.
  Kuhlen Michaela et al. Oncogene 2018 Oct
• Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
  Sylvester Dianne E et al. Journal of medical genetics 2018 Oct

more